Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease
Authors:
- Tomoyo MatsubaraTMTomoyo Matsubara
- Kazuhito JujohKJKazuhito Jujoh
- Kenji YoneKYKenji Yone
- Toshiaki SugawaraTSToshiaki Sugawara
- Keiko SasaiKSKeiko Sasai
- Hideo KatoHKHideo Kato
- Keijiro YabutaKYKeijiro Yabuta
- 1 August 1988
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 48 (2) , 247-251
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health and Welfare
This publication has 11 references indexed in Scilit:
- Plasma prostaglandin E2 level in Kawasaki diseaseProstaglandins, Leukotrienes and Essential Fatty Acids, 1988
- ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 1987
- Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome.Journal of Experimental Medicine, 1986
- Modulation of endothelial cell hemostatic properties by tumor necrosis factor.Journal of Experimental Medicine, 1986
- Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxinNature, 1984
- Human mononuclear phagocyte differentiation antigens. I. Patterns of antigenic expression on the surface of human monocytes and macrophages defined by monoclonal antibodies.The Journal of Immunology, 1983
- Prostaglandins, macrophages, and immunity.The Journal of Immunology, 1980
- Pathology of the Heart in Kawasaki DiseasePediatrics, 1978
- Morphological observations on the vasculitis in the mucocutaneous lymph node syndromeEuropean Journal of Pediatrics, 1978
- A New Infantile Acute Febrile Mucocutaneous Lymph Node Syndrome (MLNS) Prevailing in JapanPediatrics, 1974